|
|
regulation of atrial cardiac muscle cell membrane repolarization
|
GO:0060372 |
4 |
0.901
|
Human |
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.840
|
Human |
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.833
|
Human |
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.673
|
Human |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.638
|
Human |
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.613
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.550
|
Human |
|
|
action potential
|
GO:0001508 |
34 |
0.511
|
Human |
|
|
synaptic transmission
|
GO:0007268 |
61 |
0.508
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.454
|
|
|
|
system process
|
GO:0003008 |
349 |
0.442
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.420
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.413
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.401
|
Human |
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.394
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.384
|
Human |
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.361
|
Human |
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.331
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.328
|
Human |
|
|
secretion
|
GO:0046903 |
254 |
0.319
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.309
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.303
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.302
|
Human |
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.301
|
Human |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.286
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.274
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.271
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.271
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.253
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.252
|
Human |
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.251
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.248
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.247
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.246
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.243
|
|
|
|
micturition
|
GO:0060073 |
3 |
0.233
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.229
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.229
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.227
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.227
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.219
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.215
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.214
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.206
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.201
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.194
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.187
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.187
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.181
|
|
|
|
positive regulation of acrosome reaction
|
GO:2000344 |
4 |
0.179
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.179
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.173
|
Human |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.169
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.167
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.167
|
Human |
|
|
neurogenesis
|
GO:0022008 |
169 |
0.167
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.167
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.166
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.163
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.162
|
Human |
|
|
regulation of system process
|
GO:0044057 |
101 |
0.160
|
Human |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.160
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.157
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.154
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.152
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.152
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.151
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.148
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.148
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.146
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
24 |
0.144
|
Human |
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.141
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.140
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.139
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.139
|
Human |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.136
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.136
|
Human |
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.134
|
Human |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.134
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.134
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.133
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.132
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.131
|
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
3 |
0.131
|
|
|
|
potassium ion export
|
GO:0071435 |
9 |
0.131
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.130
|
|
|
|
regulation of acrosome reaction
|
GO:0060046 |
4 |
0.126
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.125
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.123
|
Human |
|
|
neuron projection development
|
GO:0031175 |
106 |
0.122
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.121
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.118
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.118
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.118
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.117
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.116
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.116
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.116
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
15 |
0.115
|
Human |
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.114
|
Human |
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.113
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.107
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.105
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.105
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.103
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.102
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.101
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.100
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.096
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.096
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.095
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.095
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.094
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.093
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.093
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.093
|
Human |
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.092
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.091
|
Human |
|
|
sensory perception
|
GO:0007600 |
103 |
0.091
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.091
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.090
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.089
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.089
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.089
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.088
|
|
|
|
memory
|
GO:0007613 |
3 |
0.086
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.086
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.085
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.082
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.082
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.080
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.079
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.079
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.079
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.077
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.077
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.076
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
43 |
0.075
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.074
|
Human |
|
|
head development
|
GO:0060322 |
108 |
0.074
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.071
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
53 |
0.071
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.071
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.071
|
Human |
|
|
regulation of muscle contraction
|
GO:0006937 |
45 |
0.071
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.070
|
|
|
|
potassium ion import
|
GO:0010107 |
9 |
0.070
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.069
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
33 |
0.069
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.069
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.069
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.069
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.069
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.067
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.067
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.067
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.065
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.065
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.065
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.065
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.064
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.063
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
37 |
0.062
|
Human |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.061
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.060
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.060
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.059
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.059
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.059
|
|
|
|
mating
|
GO:0007618 |
1 |
0.059
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.059
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.059
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.058
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.058
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.058
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.058
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.057
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.057
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.057
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.056
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.056
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.056
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.056
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.054
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.054
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.054
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.054
|
|
|
|
drinking behavior
|
GO:0042756 |
1 |
0.054
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.054
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.053
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
41 |
0.053
|
Human |
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.053
|
Human |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.053
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.052
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.052
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.051
|
|
|
|
regulation of heart rate
|
GO:0002027 |
38 |
0.051
|
Human |
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.050
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
1 |
0.050
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.050
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.050
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.050
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.049
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.049
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.049
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.049
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.048
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.048
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.048
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
40 |
0.047
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.047
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.047
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.046
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.046
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
76 |
0.046
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.046
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.045
|
|
|
|
growth
|
GO:0040007 |
202 |
0.045
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
17 |
0.045
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.045
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.044
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.044
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.044
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.044
|
Human |
|
|
regulation of potassium ion export
|
GO:1902302 |
1 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.044
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.044
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.043
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.043
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.043
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.043
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.043
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.043
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.043
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.043
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.042
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.042
|
|
|
|
startle response
|
GO:0001964 |
3 |
0.041
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.041
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.041
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.041
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.041
|
Human |
|
|
positive regulation of steroid hormone biosynthetic process
|
GO:0090031 |
2 |
0.041
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.040
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.039
|
|
|
|
regulation of synaptic transmission
|
GO:0050804 |
11 |
0.039
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.039
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.039
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.038
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.038
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.038
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.038
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.038
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.038
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.038
|
Human |
|
|
female gamete generation
|
GO:0007292 |
2 |
0.038
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.037
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.037
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.037
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.037
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.037
|
|
|
|
ionotropic glutamate receptor signaling pathway
|
GO:0035235 |
16 |
0.037
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.037
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.036
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.036
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.036
|
Human |
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.036
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.036
|
|
|
|
regulation of heart rate by cardiac conduction
|
GO:0086091 |
19 |
0.036
|
Human |
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.035
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.035
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.035
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.035
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.035
|
|
|
|
serotonin transport
|
GO:0006837 |
3 |
0.035
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.035
|
Human |
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.035
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.034
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.034
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.034
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.034
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
2 |
0.034
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
23 |
0.034
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.034
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
12 |
0.034
|
Human |
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.034
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
1 |
0.034
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.033
|
Human |
|
|
visual learning
|
GO:0008542 |
1 |
0.033
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.033
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.033
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.033
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.033
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.032
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.032
|
|
|
|
regulation of actin filament based movement
|
GO:1903115 |
24 |
0.032
|
Human |
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
43 |
0.032
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.032
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.032
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.032
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.032
|
|
|
|
positive regulation of glucocorticoid secretion
|
GO:2000851 |
4 |
0.031
|
|
|
|
cardiac muscle cell action potential involved in contraction
|
GO:0086002 |
21 |
0.031
|
Human |
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.031
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.031
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.031
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.031
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.031
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.031
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.031
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.031
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.031
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.030
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.030
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.030
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
35 |
0.030
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.030
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.030
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.030
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.030
|
|
|
|
regulation of acetylcholine gated cation channel activity
|
GO:1903048 |
1 |
0.030
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.030
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.030
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
22 |
0.030
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.030
|
|
|
|
negative regulation of synaptic transmission
|
GO:0050805 |
2 |
0.029
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.029
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.029
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.029
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.029
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.029
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.029
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.029
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
23 |
0.029
|
Human |
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.029
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.029
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.028
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.028
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
23 |
0.028
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.028
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.028
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.028
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.028
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.028
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.028
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.028
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.028
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.028
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
1 |
0.028
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.028
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.027
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.027
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.027
|
|
|
|
cardiac conduction
|
GO:0061337 |
23 |
0.027
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.027
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.027
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.027
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.027
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.027
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.027
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.027
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.027
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.027
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.027
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.027
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.026
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.026
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.026
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.026
|
|
|
|
adenylate cyclase inhibiting adrenergic receptor signaling pathway
|
GO:0071881 |
1 |
0.026
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.026
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.026
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.026
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
1 |
0.026
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.026
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
19 |
0.026
|
|
|
|
regulation of insulin secretion
|
GO:0050796 |
33 |
0.026
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.025
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.025
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.025
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.025
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
11 |
0.025
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.025
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.025
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.025
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.025
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.025
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
1 |
0.024
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.024
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
1 |
0.024
|
|
|
|
regulation of ventricular cardiac muscle cell membrane repolarization
|
GO:0060307 |
10 |
0.024
|
Human |
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.024
|
|
|
|
adult behavior
|
GO:0030534 |
18 |
0.024
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.024
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.024
|
|
|
|
adenylate cyclase inhibiting opioid receptor signaling pathway
|
GO:0031635 |
1 |
0.024
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.024
|
Human |
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.024
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
119 |
0.024
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.023
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.023
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.023
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.023
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
4 |
0.023
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.023
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.023
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.023
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.023
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.023
|
|
|
|
thalamus development
|
GO:0021794 |
2 |
0.023
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
4 |
0.022
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.022
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.022
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.022
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.022
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.022
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
1 |
0.022
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
3 |
0.022
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.022
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.022
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.022
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.021
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.021
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.021
|
|
|
|
synaptic transmission glycinergic
|
GO:0060012 |
1 |
0.021
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.021
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.021
|
|
|
|
fear response
|
GO:0042596 |
0 |
0.021
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.021
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.021
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.021
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
3 |
0.021
|
|
|
|
negative regulation of potassium ion export
|
GO:1902303 |
1 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.021
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.021
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.021
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.021
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.021
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.020
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.020
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.020
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
39 |
0.020
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.020
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.020
|
Human |
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.020
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.020
|
|
|
|
regulation of large conductance calcium activated potassium channel activity
|
GO:1902606 |
2 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.020
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.020
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.020
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.020
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.020
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.020
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.020
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.020
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.020
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.020
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.019
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
1 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.019
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.019
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.019
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.019
|
|
|
|
regulation of cell cell adhesion
|
GO:0022407 |
57 |
0.019
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
45 |
0.019
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.019
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.019
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.019
|
|
